Marra Giancarlo, Calleris Giorgio, Massari Emilia, Vissio Elena, Molinaro Luca, Cassoni Paola, D'Agate Daniele, Oderda Marco, Valerio Massimo, Raskin Yannick, Joniau Steven, Papotti Mauro, Gontero Paolo
Department of Surgical Sciences and Urology Clinic, University of Turin and Città della Salute e della Scienza, Turin, Italy.
Department of Pathology, University of Turin and Città della Salute e della Scienza, Turin, Italy.
Eur Urol Open Sci. 2022 Dec 15;47:110-118. doi: 10.1016/j.euros.2022.11.017. eCollection 2023 Jan.
Most prostate cancer (PCa) recurrences after nonsurgical first-line treatment are managed with androgen deprivation therapy (ADT). When local treatment is indicated, salvage focal treatment (FT) may achieve outcomes similar to those after salvage radical prostatectomy (sRP), with lower morbidity. However, descriptions of the topography of PCa recurrence are scarce.
To describe the characteristics and topography of recurrent PCa at sRP.
We performed a review of the final pathology for consecutive men undergoing sRP at a single centre between 2007 and 2021.
Clinical and pathological outcomes and recurrence localisation (standardised map) were recorded. Suitability for salvage FT was evaluated using criteria defined a priori.
We included 41 men who underwent sRP after whole-gland treatment (82.9% primary radiotherapy). Of these, 68.3% had grade group ≥3 and 46.3% had pT3 disease, including nine men (22%) with seminal vesicle involvement >1 cm. The pN+ rate was 29.3%. Surgical margins were positive in 39% (mostly at the apex, 21.9%). PCa was located at <3 mm from the apex in 68% of cases. The segment most frequently involved was the mid-gland (93%). The median prostate and index lesion (IL) volume was 31.4 cm (interquartile range [IQR] 23-37) and 2 cm (IQR 0.5-6), respectively. A solitary IL was present in 63.4% of cases, while 7.3% had whole-gland PCa involvement. Overall, 56% of the men ( = 23) were deemed suitable for salvage FT (although seven had pN+ disease). The sample size, single-centre retrospective design, and unavailability of magnetic resonance imaging data are the main limitations.
According to sRP pathology, radiorecurrent PCa is an aggressive disease, frequently showing extraprostatic extension, positive margins, and apical involvement. The majority of cases still harbour a solitary index lesion and a consistent proportion may be suitable for a gland-preserving strategy.
In this report we looked at the location of prostate cancer recurrence within the prostate gland after radiotherapy or ablation, in which energy (such as heat, cold, or laser energy) is used to kill cells. We found that although these recurrences are often high-grade locally advanced disease, around half of cases might be suitable for a gland-preserving salvage treatment.
大多数非手术一线治疗后的前列腺癌(PCa)复发采用雄激素剥夺疗法(ADT)进行处理。当需要进行局部治疗时,挽救性局部治疗(FT)可能会取得与挽救性根治性前列腺切除术(sRP)相似的效果,且发病率更低。然而,关于PCa复发部位的描述却很少。
描述sRP时复发性PCa的特征和部位。
设计、设置与参与者:我们对2007年至2021年期间在单一中心接受sRP的连续男性患者的最终病理进行了回顾。
记录临床和病理结果以及复发定位(标准化图谱)。使用预先定义的标准评估挽救性FT的适用性。
我们纳入了41例在全腺治疗后接受sRP的男性患者(82.9%为原发性放疗)。其中,68.3%的患者分级组≥3,46.3%的患者有pT3期疾病,包括9例(22%)精囊受累>1 cm的患者。pN+率为29.3%。手术切缘阳性率为39%(主要在尖部,21.9%)。68%的病例中PCa位于距尖部<3 mm处。最常受累的节段是腺中叶(93%)。前列腺和索引病灶(IL)的中位体积分别为31.4 cm(四分位间距[IQR] 23 - 37)和2 cm(IQR 0.5 - 6)。63.4%的病例存在单个IL,而7.3%的病例全腺均有PCa累及。总体而言,56%的男性患者(n = 23)被认为适合进行挽救性FT(尽管7例有pN+疾病)。样本量、单中心回顾性设计以及磁共振成像数据不可用是主要局限性。
根据sRP病理,放疗后复发性PCa是一种侵袭性疾病,常表现为前列腺外侵犯、切缘阳性和尖部受累。大多数病例仍有单个索引病灶,且相当比例的病例可能适合保留腺体的策略。
在本报告中,我们研究了放疗或消融(其中使用能量,如热、冷或激光能量来杀死细胞)后前列腺癌在前列腺内的复发位置。我们发现,尽管这些复发通常是高级别局部晚期疾病,但约一半的病例可能适合进行保留腺体的挽救性治疗。